Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Treating Gram-positive infections: vancomycin update and the whys, wherefores and evidence base for continuous infusion of anti-Gram-positive antibiotics
Current Opinion in Infectious Diseases, 11/02/09
Chua K et al. – Vancomycin remains an important first–line antimicrobial for treatment of serious methicillin–resistant S. aureus infections; however, a detailed analysis of isolate susceptibility and appropriate dosing are important. Although continuous infusion of some anti–Gram–positive antimicrobials may provide theoretical benefits, clinical trials demonstrating superiority in outcomes are uncommon. Use of continuous infusion may, however, provide practical advantages in patients on home intravenous antibiotics.
Today in Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Erysipeloid: a review
Clinical and Experimental Dermatology, 09/18/09
HIV-Specific Health Care Utilization and Mortality among Tuberculosis/HIV Coinfected Persons
AIDS Patient Care and STDs, 10/06/09
Influenza Management Guide 2009-2010
American Family Physician, 11/18/09
Sponsor
Article Search
Sponsor


See Latest Articles


